In the clinical research industry, sponsors are the ones who fund every trial. These sponsors or CROs can be pharma or bio companies which invest large amounts of money for conducting research. Sponsors will typically choose one or multiple research sites, depending on the size of the study and the required number of enrolled participants. One of the biggest concerns of all clinical research sites is being selected to conduct a study. Usually, after interested sites place a bid on a certain study, the sponsor will send a feasibility questionnaire to the sites he or she is interested in. After the sites fill out this feasibility report, the sponsor will choose one or multiple sites and go on a site selection visit. The site selection visit is the last step before you’re officially given the study to conduct. For this reason, sites should be especially attentive, make sure that everything goes as planned on these visits, and ensure that everything that the sponsor is going to see at the site fits the feasibility questionnaire they filled out earlier. The site selection visit is basically a confirmation that what you’ve stated in the questionnaire is actually true in practice. However, no matter how much sites try to take care of every detail, sometimes the sponsor will still find an objection. When this happens, sites need to learn how to handle it properly and give the right answers.